PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 156 filers reported holding PRECIGEN INC in Q2 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $313,915 | +41.8% | 221,067 | +14.8% | 0.00% | – |
Q2 2023 | $221,413 | -84.1% | 192,533 | -85.3% | 0.00% | – |
Q1 2023 | $1,389,035 | +714.4% | 1,310,411 | +1067.8% | 0.00% | – |
Q4 2022 | $170,568 | -15.1% | 112,216 | +18.2% | 0.00% | – |
Q3 2022 | $201,000 | +179.2% | 94,964 | +75.1% | 0.00% | – |
Q2 2022 | $72,000 | -19.1% | 54,240 | +28.9% | 0.00% | – |
Q1 2022 | $89,000 | -89.7% | 42,072 | -82.0% | 0.00% | – |
Q4 2021 | $868,000 | +180.9% | 234,192 | +277.5% | 0.00% | – |
Q3 2021 | $309,000 | -15.3% | 62,043 | +10.6% | 0.00% | – |
Q2 2021 | $365,000 | -23.0% | 56,079 | -18.5% | 0.00% | – |
Q1 2021 | $474,000 | +1.7% | 68,850 | +50.8% | 0.00% | – |
Q4 2020 | $466,000 | +43.8% | 45,670 | -50.7% | 0.00% | – |
Q3 2020 | $324,000 | -20.2% | 92,629 | +13.7% | 0.00% | – |
Q2 2020 | $406,000 | +147.6% | 81,469 | +68.7% | 0.00% | – |
Q1 2020 | $164,000 | – | 48,286 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
EMFO, LLC | 425,000 | $603,500 | 0.57% |
Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
First Washington CORP | 646,575 | $918,137 | 0.37% |
Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |